OBJECTIVE: To study the association between dietary and serum antioxidant vitamins and carotenoids and risk for colorectal cancer in male smokers. DESIGN: A prospective cohort study within a randomised, double-blind, placebo-controlled trial testing supplementation with alpha-tocopherol (50 mg/day), beta-carotene (20 mg/day) or both in preventing cancer. SUBJECTS AND METHODS: Participants of the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study with complete dietary data and serum samples available from baseline. These included 26,951 middle-aged male smokers among whom 184 colorectal cancer cases were diagnosed during 8 y of follow-up. Relative risks were calculated with Cox proportional hazards models adjusting for trial supplementation, age, body mass index, serum cholesterol, cigarettes smoked per day and physical activity. RESULTS: There was no significant association between dietary vitamin C or E, alpha-or gamma-tocopherol, retinol, alpha- or beta-carotene, lycopene or lutein+zeaxanthin and risk for colorectal cancer. Serum alpha-tocopherol, beta-carotene or retinol was also not associated with the risk, neither did the season when baseline blood was drawn modify the relationship between serum beta-carotene and colorectal cancer risk. CONCLUSIONS: Our data support the results from previous studies in which no association between dietary antioxidant vitamins and carotenoids and risk for colorectal cancer has been observed. Likewise, no association between baseline serum antioxidant concentrations and colorectal cancer risk was evident. SPONSORSHIP: The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study was supported by a contract with the US National Cancer Institute (N01-CN-45165).
RCT Entities:
OBJECTIVE: To study the association between dietary and serum antioxidant vitamins and carotenoids and risk for colorectal cancer in male smokers. DESIGN: A prospective cohort study within a randomised, double-blind, placebo-controlled trial testing supplementation with alpha-tocopherol (50 mg/day), beta-carotene (20 mg/day) or both in preventing cancer. SUBJECTS AND METHODS: Participants of the Alpha-Tocopherol, Beta-CaroteneCancer Prevention Study with complete dietary data and serum samples available from baseline. These included 26,951 middle-aged male smokers among whom 184 colorectal cancer cases were diagnosed during 8 y of follow-up. Relative risks were calculated with Cox proportional hazards models adjusting for trial supplementation, age, body mass index, serum cholesterol, cigarettes smoked per day and physical activity. RESULTS: There was no significant association between dietary vitamin C or E, alpha-or gamma-tocopherol, retinol, alpha- or beta-carotene, lycopene or lutein+zeaxanthin and risk for colorectal cancer. Serum alpha-tocopherol, beta-carotene or retinol was also not associated with the risk, neither did the season when baseline blood was drawn modify the relationship between serum beta-carotene and colorectal cancer risk. CONCLUSIONS: Our data support the results from previous studies in which no association between dietary antioxidant vitamins and carotenoids and risk for colorectal cancer has been observed. Likewise, no association between baseline serum antioxidant concentrations and colorectal cancer risk was evident. SPONSORSHIP: The Alpha-Tocopherol, Beta-CaroteneCancer Prevention Study was supported by a contract with the US National Cancer Institute (N01-CN-45165).
Authors: Yikyung Park; Donna Spiegelman; David J Hunter; Demetrius Albanes; Leif Bergkvist; Julie E Buring; Jo L Freudenheim; Edward Giovannucci; R Alexandra Goldbohm; Lisa Harnack; Ikuko Kato; Vittorio Krogh; Michael F Leitzmann; Paul J Limburg; James R Marshall; Marjorie L McCullough; Anthony B Miller; Thomas E Rohan; Arthur Schatzkin; Roy Shore; Sabina Sieri; Meir J Stampfer; Jarmo Virtamo; Matty Weijenberg; Walter C Willett; Alicja Wolk; Shumin M Zhang; Stephanie A Smith-Warner Journal: Cancer Causes Control Date: 2010-09-05 Impact factor: 2.506
Authors: Deborah L Bella; Bettina C Schock; Yunsook Lim; Scott W Leonard; Crystal Berry; Carroll E Cross; Maret G Traber Journal: Lipids Date: 2006-02 Impact factor: 1.880
Authors: Konstantinos K Tsilidis; Nikos Papadimitriou; Niki Dimou; Dipender Gill; Sarah J Lewis; Richard M Martin; Neil Murphy; Georgios Markozannes; Verena Zuber; Amanda J Cross; Kimberley Burrows; David S Lopez; Timothy J Key; Ruth C Travis; Aurora Perez-Cornago; David J Hunter; Fränzel J B van Duijnhoven; Demetrius Albanes; Volker Arndt; Sonja I Berndt; Stéphane Bézieau; D Timothy Bishop; Juergen Boehm; Hermann Brenner; Andrea Burnett-Hartman; Peter T Campbell; Graham Casey; Sergi Castellví-Bel; Andrew T Chan; Jenny Chang-Claude; Albert de la Chapelle; Jane C Figueiredo; Steven J Gallinger; Graham G Giles; Phyllis J Goodman; Andrea Gsur; Jochen Hampe; Heather Hampel; Michael Hoffmeister; Mark A Jenkins; Temitope O Keku; Sun-Seog Kweon; Susanna C Larsson; Loic Le Marchand; Christopher I Li; Li Li; Annika Lindblom; Vicente Martín; Roger L Milne; Victor Moreno; Hongmei Nan; Rami Nassir; Polly A Newcomb; Kenneth Offit; Paul D P Pharoah; Elizabeth A Platz; John D Potter; Lihong Qi; Gad Rennert; Lori C Sakoda; Clemens Schafmayer; Martha L Slattery; Linda Snetselaar; Jeanette Schenk; Stephen N Thibodeau; Cornelia M Ulrich; Bethany Van Guelpen; Sophia Harlid; Kala Visvanathan; Ludmila Vodickova; Hansong Wang; Emily White; Alicja Wolk; Michael O Woods; Anna H Wu; Wei Zheng; Bas Bueno-de-Mesquita; Marie-Christine Boutron-Ruault; David J Hughes; Paula Jakszyn; Tilman Kühn; Domenico Palli; Elio Riboli; Edward L Giovannucci; Barbara L Banbury; Stephen B Gruber; Ulrike Peters; Marc J Gunter Journal: Am J Clin Nutr Date: 2021-06-01 Impact factor: 7.045
Authors: Goran Bjelakovic; Dimitrinka Nikolova; Lise Lotte Gluud; Rosa G Simonetti; Christian Gluud Journal: Cochrane Database Syst Rev Date: 2012-03-14
Authors: Song-Yi Park; Abraham M Y Nomura; Suzanne P Murphy; Lynne R Wilkens; Brian E Henderson; Laurence N Kolonel Journal: J Epidemiol Date: 2009-03-06 Impact factor: 3.211
Authors: P D Karkos; S C Leong; C D Karkos; N Sivaji; D A Assimakopoulos Journal: Evid Based Complement Alternat Med Date: 2010-10-19 Impact factor: 2.629